Dynamin function in pancreatic beta-cell autophagy
Dynamin function in pancreatic beta-cell autophagy
批准号:
10693338
负责人:
Xuelin Lou
金额:
$39.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-30 至 2025-07-31
关键词:
AcetylationAffectAmericanAnimalsAutophagocytosisBeta CellBindingBiochemicalBiochemistryBiological AssayCell LineCell physiologyCellular biologyChronicCytoprotectionDataDefectDevelopmentDiabetes MellitusDietDynaminDynamin 2Dynamin IIIEatingEndocytosisEpidemicFailureFastingGenesGeneticGenetic ModelsGuanosine Triphosphate PhosphohydrolasesImageImaging TechniquesImpairmentIn VitroInsulinInvestmentsKnowledgeLeadLysosomesMediatingMembraneMetabolic stressMethodologyMethodsMicrotubulesModificationMolecularMusNatureNon-Insulin-Dependent Diabetes MellitusOrganPathologicPathway interactionsPatientsPharmaceutical PreparationsPhysiologicalPlayProcessProtein IsoformsRecurrent diseaseRegulationRoleSignal TransductionSourceStressStructure of beta Cell of isletTestingTherapeuticTimeTissuesTransplantationTransportationVacuoleWorkblood glucose regulationdesigndiabetes pathogenesisdiabeticfeedinggenetic approachin vivoinnovationinsightinsulin secretioninterdisciplinary approachinterestisletlive cell imagingmouse modelnovelnovel therapeuticspathogenpharmacologicpreservationpreventresponsesuperresolution imagingsuperresolution microscopytherapeutic targettooltraffickingtype I and type II diabetes
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Diabetes affects over 30 million Americans, yet its epidemic is still rising at an alarming rate. The
progressive decline of pancreatic β cell function and mass is a hallmark of diabetes, but no medications
prevent this decline. Interestingly, a fasting-mimicking diet known to activate autophagy stops this
decline and reverses diabetes in mice. Accordingly, recent progress has increasingly recognized
autophagy as a potential therapeutic target to treat diabetes because of its role in protecting β cells
against pathogens and metabolic stress. However, the basic nature of β cell autophagy remains poorly
understood, particularly in the molecular process governing autophagic membrane fission. Our recent
data uncover that dynamin, a subfamily of large GTPases known to regulate endocytosis and insulin
secretion, directly alters β cell autophagy. Live-cell imaging suggests that dynamin molecules can
translocate to autolysosomes and drive autolysosome fission. Dynamin deletion causes striking
autophagy defects in β cells in vitro and in vivo. These new findings fuel tremendous interest in
understanding the molecule mechanisms at play throughout the β cell autophagy cycle. We
hypothesize that dynamin plays a direct and crucial role in β cell autophagy flux that has not been
characterized previously. Mechanistically, we suspect that dynamin regulates β cell autophagy through
regulating autolysosome fission and autophagic transport. These processes may be essential to protect
β cells against chronic metabolic stress toward diabetes. To test the hypothesis, we have generated
dynamin isoform-specific mouse models, which allow evaluating dynamin-regulated β cell autophagy
and its protection against metabolic stress associated with diabetes. We have assembled a team with
substantial expertise in β cell biology, super-resolution imaging, biochemical signaling, and diabetes.
We will focus on three specific aims. First, define the role of dynamin in β cell autolysosome fission.
The fission step is necessary for autolysosome-to-lysosome transformation in each autophagic cycle
of β cells, but its mechanism remains poorly understood. Second, identify the role of dynamin in
regulating autophagic transport via microtubule modulation. This aim may uncover a previously
unappreciated pathway for dynamin to regulate autophagy in β cells. Third, examine how dynamin
regulates β cell autophagic responses upon metabolic stress in vivo. Together, these studies will
provide new insights into the autophagic turnover in β cells and its regulation by different dynamin
isoforms. The results will advance the fundamental understanding of β cell autophagy cycles that
profoundly impacts islet function and diabetes pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ArpC3-mediated actin remodeling in insulin granule exocytosis and diabetes
-
批准号:10583734
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2023
-
负责人:Xuelin Lou
-
依托单位:
Understanding the degeneration of axon and nerve terminals in Alzheimer's disease and related dementia brain
-
批准号:10661457
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2023
-
负责人:Xuelin Lou
-
依托单位:
Dynamin function in beta cell autophagy
-
批准号:10473913
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2021
-
负责人:Xuelin Lou
-
依托单位:
Exocytosis-endocytosis coupling at presynaptic terminals
-
批准号:9673997
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2018
-
负责人:Xuelin Lou
-
依托单位:
Regulated exocytosis and endocytosis coupling in pancreatic endocrine cells
-
批准号:8875671
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2011
-
负责人:Xuelin Lou
-
依托单位:
Regulated exocytosis and endocytosis coupling in pancreatic endocrine cells
-
批准号:8690043
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2011
-
负责人:Xuelin Lou
-
依托单位:
Regulated exocytosis and endocytosis coupling in pancreatic endocrine cells
-
批准号:8501443
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2011
-
负责人:Xuelin Lou
-
依托单位:
Regulated exocytosis and endocytosis coupling in pancreatic endocrine cells
-
批准号:8219529
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2011
-
负责人:Xuelin Lou
-
依托单位:
Regulated exocytosis and endocytosis coupling in pancreatic endocrine cells
-
批准号:8338909
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2011
-
负责人:Xuelin Lou
-
依托单位:
海外基金